SlideShare a Scribd company logo
Ultralow resections Emmanuel Tiret Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie, Paris VI
Introduction ,[object Object],[object Object],[object Object],[object Object]
Introduction ,[object Object],[object Object],[object Object]
Surgical technique ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],T
Circumferential incision of the  anal mucosa with special attention to preserve a sufficient length  of anoderm. After circumferential preparation  the rectum is mobile and the  external sphincter has been  completely preserved. Surgical technique Schiessel et al. Dis Colon Rectum 2005; 48: 1858–1867
A coloanal anastomosis is performed  with single sutures taking the anus and  parts of the external anal sphincter Surgical technique
Exclusion ,[object Object],[object Object],[object Object],[object Object],[object Object]
Preoperative radiotherapy or radiochemotherapy Rouanet et al. Ann Surg 1995; 221: 67-73 Rullier et al. Ann Surg 2001; 234: 633-40 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Patients 1992-2004 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Ann Surg 2007; 246: 916-22
Intersphincteric resections 1992-2004 : 6% of 1319 rectal adenocarcinoma
Patients ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
upper third : upper half or > : 63 (70%)   27 (30%) Level of internal sphincter excision T Median distal resection margin : 12mm (5-35)
Postoperative complications   Mortality :  0 Morbidity :  18.8% (17) Stenosis : 8.4% (8) ,[object Object],8 ,[object Object],1 ,[object Object],1 ,[object Object],2 ,[object Object],1 ,[object Object],1 ,[object Object],1 ,[object Object],1 ,[object Object],1
[object Object],[object Object],[object Object],[object Object],Results
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Oncological results
Characteristics of 6 patients with local recurrence and 2 patients with combined recurrence Ann Surg 2007; 246: 916-22
Survival Five-years overall survival  82%   IC 95% [80-97] Five-years disease free survival  75% IC 95%[64-86] Death from cancer : 14.4% (13)
Recurrence and survival Author n Stage Follow-up (months) Local recurrence Distant recurrence Survival Schiessel  121 T1-4 94 5.3% Köhler  31 T1-3 82 10% 10% 79% Rullier  92 T1-4 44 2% 19% 81% Saito  225 T1-3 41 6.7%   91.9%  Braun  63 T1-3 80 11% 33% 62% * Hohenberger St Antoine 53 90 T1-4 56.2 25.1% 6.6% 8.8% 85% 82%
Functional results at follow-up (55 months) 83 patients (colonic J-pouch)  2 patients lost of FU and 5  APR Stool frequency (per 24 hours) 2.3 ± 1.3 ,[object Object],50 (60%) ,[object Object],30 (36%) ,[object Object],3 (4%) Nocturnal defaecation 24 (29%) Urgency 16 (19%) Pad wear 38 (46%) Intestinal transit regulators 22 (26,5%) Feces-flatus discrimination 21 (25,3%) Stool fragmentation 40 (41%) Alimentary restriction 30 (36%)
Functional results  Continence at follow-up ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Relationship between level of coloanal anastomosis and complete continence ,[object Object],[object Object],[object Object],Schiessel et al. Dis Colon Rectum 2005; 48: 1858–1867
Manometry Schiessel et al. Dis Colon Rectum 2005; 48: 1858–1867 n = 117 IRS Relationship between level of coloanal anastomosis and complete continence
Factors influencing functional outcome   Univariate analysis Chamlou R et al. Ann Surg 2007; 246: 916-22
Factors influencing functional outcome Multivariate analysis OR [IC 95%] p Age 1,032 [0,984;1,084] ns Sex 1,139 [0,369;3,516] ns pT stage ,[object Object],1 ns ,[object Object],1,311 [0,436;3,948] ns Preoperative radiotherapy ,[object Object],1 ,[object Object],3,1 [1,051;8,982] 0,04
Functional result Author n  Stool frequency n/24h Normal  continence Major incontinence  Colostomy Schiessel 117  3 86.3% 0% 0 Köhler 26  3-4 29.6% 3.7% 1 Bretagnol 40 2.5 15% 12% 0 Saito 181 3-4 68%   7% 0 Braun 41 2.2 80% 3% 0 St Antoine 83 2.3 41% 2% 0
Conclusion ,[object Object],[object Object],[object Object],[object Object],[object Object]

More Related Content

What's hot

Low Anterior Resection
Low Anterior ResectionLow Anterior Resection
Low Anterior Resection
Dhaval Mangukiya
 
CARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTCARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENT
Nabeel Yahiya
 
Transanal total mesorectal excision
Transanal total mesorectal excisionTransanal total mesorectal excision
Transanal total mesorectal excision
Abhishek Thakur
 
Extralevator abdominoperineal excision
Extralevator abdominoperineal excisionExtralevator abdominoperineal excision
Extralevator abdominoperineal excision
Yannick Nijs
 
Mellss yr3 surgery tumours of rectum
Mellss  yr3 surgery tumours of rectumMellss  yr3 surgery tumours of rectum
Mellss yr3 surgery tumours of rectum
nur amalina aminuddin baki
 
Ca rectum premanagement
Ca rectum premanagementCa rectum premanagement
Ca rectum premanagement
Manish Dutt
 
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. KorkolisSurgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Dimitris P. Korkolis
 
Ca Anal Canal #Surgery
Ca Anal Canal #SurgeryCa Anal Canal #Surgery
Ca Anal Canal #Surgery
Junish Bagga
 
Extralevator abdominoperineal resection(elape)
Extralevator  abdominoperineal resection(elape)Extralevator  abdominoperineal resection(elape)
Extralevator abdominoperineal resection(elape)
Stalinsurgeon Joseph Antonymuthu
 
RECTAL CANCER adesiyakan
 RECTAL CANCER adesiyakan RECTAL CANCER adesiyakan
RECTAL CANCER adesiyakan
Adedotun Adesiyakan
 
Rectal Carcinoma
Rectal CarcinomaRectal Carcinoma
Rectal Carcinoma
Dr. Aryan (Anish Dhakal)
 
operations of Carcinoma rectum
operations of Carcinoma rectumoperations of Carcinoma rectum
operations of Carcinoma rectum
Biswajit Deka
 
Rectal cancer
Rectal cancer Rectal cancer
Rectal cancer
gastrosurgeonchennai
 
Trans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEMTrans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEM
khaled Mestareehy
 
Management of Rectal Cancer
Management of Rectal CancerManagement of Rectal Cancer
Management of Rectal Cancer
Subhash Thakur
 
Carcinoma rectum & colon part 2
Carcinoma rectum & colon part 2Carcinoma rectum & colon part 2
Carcinoma rectum & colon part 2
Ahmad Uzair Qureshi
 
Ca rectum
Ca rectumCa rectum
Ca rectum
syed ubaid
 
Rectal Cancer
Rectal CancerRectal Cancer
Rectal Cancer
Monsif Iqbal
 

What's hot (20)

Low Anterior Resection
Low Anterior ResectionLow Anterior Resection
Low Anterior Resection
 
CARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENTCARCINOMA RECTUM MANAGEMENT
CARCINOMA RECTUM MANAGEMENT
 
Transanal total mesorectal excision
Transanal total mesorectal excisionTransanal total mesorectal excision
Transanal total mesorectal excision
 
Extralevator abdominoperineal excision
Extralevator abdominoperineal excisionExtralevator abdominoperineal excision
Extralevator abdominoperineal excision
 
Mellss yr3 surgery tumours of rectum
Mellss  yr3 surgery tumours of rectumMellss  yr3 surgery tumours of rectum
Mellss yr3 surgery tumours of rectum
 
Ca rectum premanagement
Ca rectum premanagementCa rectum premanagement
Ca rectum premanagement
 
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. KorkolisSurgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
Surgery of Rectal Cancer : Potentials and Limitations - Dimitris P. Korkolis
 
Ca Anal Canal #Surgery
Ca Anal Canal #SurgeryCa Anal Canal #Surgery
Ca Anal Canal #Surgery
 
Extralevator abdominoperineal resection(elape)
Extralevator  abdominoperineal resection(elape)Extralevator  abdominoperineal resection(elape)
Extralevator abdominoperineal resection(elape)
 
RECTAL CANCER adesiyakan
 RECTAL CANCER adesiyakan RECTAL CANCER adesiyakan
RECTAL CANCER adesiyakan
 
Rectal Carcinoma
Rectal CarcinomaRectal Carcinoma
Rectal Carcinoma
 
operations of Carcinoma rectum
operations of Carcinoma rectumoperations of Carcinoma rectum
operations of Carcinoma rectum
 
Rectal cancer
Rectal cancer Rectal cancer
Rectal cancer
 
Trans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEMTrans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEM
 
Management of Rectal Cancer
Management of Rectal CancerManagement of Rectal Cancer
Management of Rectal Cancer
 
Carcinoma rectum
Carcinoma rectumCarcinoma rectum
Carcinoma rectum
 
MCC - Slide 13
MCC - Slide 13MCC - Slide 13
MCC - Slide 13
 
Carcinoma rectum & colon part 2
Carcinoma rectum & colon part 2Carcinoma rectum & colon part 2
Carcinoma rectum & colon part 2
 
Ca rectum
Ca rectumCa rectum
Ca rectum
 
Rectal Cancer
Rectal CancerRectal Cancer
Rectal Cancer
 

Similar to MCC 2011 - Slide 14

Cancers hépatiques métastatiques : Actualité 2013-2014
Cancers hépatiques métastatiques : Actualité 2013-2014Cancers hépatiques métastatiques : Actualité 2013-2014
Cancers hépatiques métastatiques : Actualité 2013-2014
Centre Hepato-Biliaire / AP-HP Hopital Paul Brousse
 
Fertility preservation in Cancer Cervix
Fertility preservation in Cancer CervixFertility preservation in Cancer Cervix
Fertility preservation in Cancer Cervix
Sujoy Dasgupta
 
Journal club
Journal clubJournal club
Journal club
mawaddahazman
 
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - SurgeryECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - SurgeryEuropean School of Oncology
 
Gi tumour
Gi tumourGi tumour
Gi tumour
elango mk
 
SBRT versus Surgery in Early lung cancer : Debate
SBRT versus Surgery in Early lung cancer : DebateSBRT versus Surgery in Early lung cancer : Debate
SBRT versus Surgery in Early lung cancer : Debate
Ruchir Bhandari
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
spa718
 
21 Century Management Of Colorectal Cancer
21 Century Management Of Colorectal Cancer21 Century Management Of Colorectal Cancer
21 Century Management Of Colorectal Cancerensteve
 
Gastric Cancer Evidence Based Management
Gastric Cancer Evidence Based ManagementGastric Cancer Evidence Based Management
Gastric Cancer Evidence Based Management
Sheetal R Kashid
 
Simon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardsSimon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standards
triumphbenelux
 
UK Urological Centre Cystectomy Service- an audit
UK Urological Centre Cystectomy Service- an auditUK Urological Centre Cystectomy Service- an audit
UK Urological Centre Cystectomy Service- an audit
bnd861
 
113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf
113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf
113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf
Ks doctor
 
Trauma and urologic reconstruction network of surgeons - MMC and BNCX
Trauma and urologic reconstruction network of surgeons - MMC and BNCXTrauma and urologic reconstruction network of surgeons - MMC and BNCX
Trauma and urologic reconstruction network of surgeons - MMC and BNCX
jeremybmyers
 
4 dr mario sideri m k
4  dr mario sideri  m k4  dr mario sideri  m k
4 dr mario sideri m k
Tariq Mohammed
 
Radiotherapy for bladder cancers
Radiotherapy for bladder cancersRadiotherapy for bladder cancers
Radiotherapy for bladder cancersAshutosh Mukherji
 
Lung cancer
Lung cancerLung cancer
Lung cancer
Gurneet Singh
 
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerBladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
BJUI
 

Similar to MCC 2011 - Slide 14 (20)

Cancers hépatiques métastatiques : Actualité 2013-2014
Cancers hépatiques métastatiques : Actualité 2013-2014Cancers hépatiques métastatiques : Actualité 2013-2014
Cancers hépatiques métastatiques : Actualité 2013-2014
 
Fertility preservation in Cancer Cervix
Fertility preservation in Cancer CervixFertility preservation in Cancer Cervix
Fertility preservation in Cancer Cervix
 
Journal club
Journal clubJournal club
Journal club
 
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - SurgeryECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
ECCLU 2011 - G. Thalmann - Localised invasive bladder cancer - Surgery
 
Gi tumour
Gi tumourGi tumour
Gi tumour
 
Role of CT Urography in bladder cancer. Cambridge lecture.
Role of CT Urography in bladder cancer. Cambridge lecture.Role of CT Urography in bladder cancer. Cambridge lecture.
Role of CT Urography in bladder cancer. Cambridge lecture.
 
SBRT versus Surgery in Early lung cancer : Debate
SBRT versus Surgery in Early lung cancer : DebateSBRT versus Surgery in Early lung cancer : Debate
SBRT versus Surgery in Early lung cancer : Debate
 
Controversies in Colorectal Cancer
Controversies in Colorectal CancerControversies in Colorectal Cancer
Controversies in Colorectal Cancer
 
21 Century Management Of Colorectal Cancer
21 Century Management Of Colorectal Cancer21 Century Management Of Colorectal Cancer
21 Century Management Of Colorectal Cancer
 
MCC 2011 - Slide 28
MCC 2011 - Slide 28MCC 2011 - Slide 28
MCC 2011 - Slide 28
 
Gastric Cancer Evidence Based Management
Gastric Cancer Evidence Based ManagementGastric Cancer Evidence Based Management
Gastric Cancer Evidence Based Management
 
Simon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standardsSimon Leeson - Colposcopic treatment standards
Simon Leeson - Colposcopic treatment standards
 
UK Urological Centre Cystectomy Service- an audit
UK Urological Centre Cystectomy Service- an auditUK Urological Centre Cystectomy Service- an audit
UK Urological Centre Cystectomy Service- an audit
 
113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf
113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf
113/02/16-達文西機械手臂手術於耳鼻喉之應用-講師:蘇彥燁主治醫師.pdf
 
Trauma and urologic reconstruction network of surgeons - MMC and BNCX
Trauma and urologic reconstruction network of surgeons - MMC and BNCXTrauma and urologic reconstruction network of surgeons - MMC and BNCX
Trauma and urologic reconstruction network of surgeons - MMC and BNCX
 
MCC 2011 - Slide 7
MCC 2011 - Slide 7MCC 2011 - Slide 7
MCC 2011 - Slide 7
 
4 dr mario sideri m k
4  dr mario sideri  m k4  dr mario sideri  m k
4 dr mario sideri m k
 
Radiotherapy for bladder cancers
Radiotherapy for bladder cancersRadiotherapy for bladder cancers
Radiotherapy for bladder cancers
 
Lung cancer
Lung cancerLung cancer
Lung cancer
 
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder CancerBladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
Bladder-Sparing Trimodality Therapy for Muscle-Invasive Bladder Cancer
 

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 

MCC 2011 - Slide 14

  • 1. Ultralow resections Emmanuel Tiret Hôpital Saint-Antoine, AP-HP Université Pierre et Marie Curie, Paris VI
  • 2.
  • 3.
  • 4.
  • 5. Circumferential incision of the anal mucosa with special attention to preserve a sufficient length of anoderm. After circumferential preparation the rectum is mobile and the external sphincter has been completely preserved. Surgical technique Schiessel et al. Dis Colon Rectum 2005; 48: 1858–1867
  • 6. A coloanal anastomosis is performed with single sutures taking the anus and parts of the external anal sphincter Surgical technique
  • 7.
  • 8.
  • 9.
  • 10. Intersphincteric resections 1992-2004 : 6% of 1319 rectal adenocarcinoma
  • 11.
  • 12. upper third : upper half or > : 63 (70%) 27 (30%) Level of internal sphincter excision T Median distal resection margin : 12mm (5-35)
  • 13.
  • 14.
  • 15.
  • 16. Characteristics of 6 patients with local recurrence and 2 patients with combined recurrence Ann Surg 2007; 246: 916-22
  • 17. Survival Five-years overall survival 82% IC 95% [80-97] Five-years disease free survival 75% IC 95%[64-86] Death from cancer : 14.4% (13)
  • 18. Recurrence and survival Author n Stage Follow-up (months) Local recurrence Distant recurrence Survival Schiessel 121 T1-4 94 5.3% Köhler 31 T1-3 82 10% 10% 79% Rullier 92 T1-4 44 2% 19% 81% Saito 225 T1-3 41 6.7%   91.9% Braun 63 T1-3 80 11% 33% 62% * Hohenberger St Antoine 53 90 T1-4 56.2 25.1% 6.6% 8.8% 85% 82%
  • 19.
  • 20.
  • 21.
  • 22. Manometry Schiessel et al. Dis Colon Rectum 2005; 48: 1858–1867 n = 117 IRS Relationship between level of coloanal anastomosis and complete continence
  • 23. Factors influencing functional outcome Univariate analysis Chamlou R et al. Ann Surg 2007; 246: 916-22
  • 24.
  • 25. Functional result Author n Stool frequency n/24h Normal continence Major incontinence Colostomy Schiessel 117 3 86.3% 0% 0 Köhler 26 3-4 29.6% 3.7% 1 Bretagnol 40 2.5 15% 12% 0 Saito 181 3-4 68%   7% 0 Braun 41 2.2 80% 3% 0 St Antoine 83 2.3 41% 2% 0
  • 26.